- Biedenkopf, N., Lange-Grünweller, K., Schulte, F. W., Weißer, A., Müller, C., Becker, D., Becker, S., Hartmann & Grünweller, A. The natural compound silvestrol is a potent inhibitor of Ebola virus replication. Antiviral Research 2017, 137, 76-81.
- Baumann, B. F., Bohnenstengel, D., Siegmund, H., Wajant, C., Weber, I., Herr, K.M., Debatin, P. Proksch, P. and Wirth, T. Rocaglamide derivatives are potent inhibitors of NF-_B activation in T-cells. J. Biol. Chem. 2002, 277: 44791–44800.
- Bohnenstengel, F.I., Steube, K.G., Meyer, C., Nugroho, B.W., Hung, P.D., Kiet, L.C. and Proksch P. Structure activity relationships of antiproliferative rocaglamide derivatives from Aglaia species (Meliaceae). Z Naturforsch [C] 1999, 54: 55-6.
- Bordeleau M.E., Robert, F., Gerard, B., Lindqvist, L., Chen, S.M-H., Wendel, H.G., Brem, B., Greger, H., Lowe, S.W., Porco, J.A. and Pelletier, J. Therapeutic suppression of translation initiation modulates chemosensitivity in a mouse lymphoma model. J Clin Inv. 2008, 118: 1–11.
- Christensen, H. 2002. Ethnobotany of the Iban and the Kelabit. Joint Publication of Forest Department Sarawak, NEPCon and University of Aarhus. Videbaek, Denmark.
- El Sous, M., Khoo, M.L., Holloway, G., Owen, D., Scammells, P.J. and Rizzacasa, M.A. Total synthesis of (-)-episilvestrol and (-)-silvestrol. Angew Chem Int Ed Engl. 2007, 46(41):7835-8.
- Fahrig, T., Gerlach, I. and Horvath, E. 2005. A synthetic derivative of the natural product rocaglaol is a potent inhibitor of cytokine mediated signaling and shows neuroprotective activity in vitro and in animal models of Parkinson's disease and traumatic brain injury. Mol Pharmacol. 2007, 67: 1544-1555.
- Gerard, B., Cencic, R., Pelletier, J. and Porco, J.A .Jr. Enantioselective synthesis of the complex rocaglate (-)-silvestrol. Angew Chem Int Ed Engl. 2009, 46(41):7831-4.
- Hwang, B.Y., Su, B.N., Chai, H., Mi, Q., Kardono, L.B., Afriastini, J.J., Riswan, S., Santarsiero, B.D., Mesecar, A.D., Wild, R., Fairchild, C.R., Vite, G.D., Rose, W.C., Farnsworth, N.R., Cordell, G.A., Pezzuto, J.M., Swanson, S.M. and Kinghorn, A.D. Silvestrol and episilvestrol, potential anticancer rocaglate derivatives from Aglaia silvestris. J Org Chem. 2004, 69: 3350-3358.
- Hwang, B.Y., Su, B.N., Chai, H., Mi, Q., Kardono, L.B., Afriastini, J.J., Riswan, S., Santarsiero, B.D., Mesecar, A.D., Wild, R., Fairchild, C.R., Vite, G.D., Rose, W.C., Farnsworth, N.R., Cordell, G.A., Pezzuto, J.M., Swanson, S.M. and Kinghorn, A.D. Silvestrol and episilvestrol, potential anticancer rocaglate derivatives from Aglaia silvestris. J Org Chem. 2004, 69:6156. (erratum)
- King, M.L., Chiang, C.C., Ling, H.C., Fujita, E., Ochiai, M. and McPhail, A.T., X-ray crystal structure of rocaglamide, a novel antileukemic 1H-cyclopenta[b]benzofuran from Aglaia elliptifolia. J Chem Soc, Chem Comm. 1982, 1150-1151.
- Kim, S., Hwang, B.Y., Su, B., Chai, H., Mi, Q., Kinghorn, A.D., Wild, R., Swanson, S.M., Silvestrol, a potential anticancer rocaglate derivative from Aglaia foveolata, induces apoptosis in LNCaP cells through the mitochondrial/apoptosome pathway without activation of executioner caspase-3 or 7. Anticancer Research. 27(4B): 2175-2183.
- Lucas, D.M., Edwards, R.B., Lozanski, G., West, D.A., Shin, J.D., Vargo, M.A., Davis, M.E., Rozewski, D.M., Johnson, A.J., Su, B.N., Goettl, V.M., Heerema, N.A., Lin, T.S., Lehman, A., Zhang, X., Jarjoura, D., Newman, D.J., Byrd, J.C. and Kinghorn, A.D., Grever, M.R., 2009. The novel plant-derived agent silvestrol has B-cell selective activity in chronic lymphocytic leukemia and acute lymphoblastic leukemia in vitro and in vivo. Blood 113(19): 4656-4666.
- Mi,Q., Kim, S., Hwang, B.Y., Hwang, B.A., Su, B., Chai, H., Arbieva, Z.H., Kinghorn, A.G. and Swanson, S., 2006. Silvestrol regulates G2/M checkpoint genes independent of p53 activity. Anticancer Res. 26:3349-3356.
- Meurer-Grimes, B.M., Yu, J. and Viaro, G.L., 2004. Therapeutic compounds and methods. US Patent 6,710,075B2.
- Proksch, P., Edrada, R., Ebel, R., Bohnenstengel, F.I.,and Nugroho, B.W., 2001. Chemistry and biological activity of rocaglamide derivatives and related compounds in Aglaia species (Meliaceae). Curr Org Chem 5: 923- 938.
- Proksch, P., Giaisi, M., Treiber, M.K., Palfi, K., Merling, A., Spring, H., Krammer, P.H. and Li-Weber, M., 2005. Rocaglamide derivatives are immunosuppressive phytochemicals that target NF-AT activity in T cells. J Immunol 174: 7075-7084.
- Rivero-Cruz, J.F., Chai, H.B., Kardono, L.B., Setyowati, F.M., Afriatini, J.J., Riswan, S., Farnsworth, N.R., Cordell,G.A., Pezzuto, J.M., Swanson, S.M. and Kinghorn, A.D., 2004. Cytotoxic constituents of the twigs and leaves of Aglaia rubiginosa. J. Nat. Prod. 67(3), 343-347.
- Salim, A.A., Chai, H., Rachman, I., Riswan, S., Kardono, L.b.s., Farnsworth, N.R., Carcache-Blanco, E.J., Kinghorn, A.D., 2007. Constituents of the leaves and stem bark of Aglaia foveolata. Tetrahedron 63(33): 7926-7934.
- Soepadmo, E., (Ed.), 2007. Tree flora of Sabah and Sarawak (vol. 6) Malaysia, Ampang Press Sdn. Bhd.